[1]
L. Valdesoiro-Navarrete, “Combination therapy of specific aeroallergens immunotherapy and omalizumab, in children with severe asthma”, Allergol Immunopathol, vol. 50, no. 2, pp. 1–6, Mar. 2022, doi: 10.15586/aei.v50i2.469.